Atlas Antibodies AB
13Patents
13Active
13Granted
47Portfolio score
Filing activity: Jun 4, 2007 → Apr 9, 2014 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8999656B2 | PODXL protein in colorectal cancer | Physics | 143 | Active |
| US9063149B2 | Quantitative standard for mass spectrometry of proteins | Chemistry; Metallurgy | 8 | Active |
| US8067190B2 | Use of protein SATB2 as a marker for colorectal cancer | Physics | 2 | Active |
| US8465934B2 | Use of protein SATB2 as a marker for colorectal cancer | Physics | 1 | Active |
| US8632984B2 | RBM3 as a marker for malignant melanoma prognosis | Physics | 1 | Active |
| US8747910B2 | Prediction of response to platinum-based therapy | Physics | 1 | Active |
| US9701741B2 | RBM3 in bladder cancer | Chemistry; Metallurgy | 1 | Active |
| US8728739B2 | RBM3 in colorectal cancer prognostics | Chemistry; Metallurgy | 0 | Active |
| US8945832B2 | Treatment prediction involving HMGCR | Physics | 0 | Active |
| US9416176B2 | RBM3 protein in colorectal cancer prognostics | Chemistry; Metallurgy | 0 | Active |
| US9354232B2 | PODXL in bladder cancer | Physics | 0 | Active |
| US8420788B2 | Epitopes derived from SATB2 and uses thereof | Physics | 0 | Active |
| US8241859B2 | Use of protein SATB2 as a marker for colorectal cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.